Clinical Trial Update: A Pilot Study to Determine Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Acne Scarring [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 pilot study evaluated the safety and potential efficacy of autologous human platelet lysate for acne scarring; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Scarring

Drugs mentioned

• Autologous Human Platelet Lysate (HPL) (platelet lysate)

Snippet

Sponsor: Kasiak Research Pvt. Ltd. | Conditions: ACNE SCARRING | Phase 1, Phase 2 | Status: COMPLETED